|
Genomewide Search for Loci Underlying Metabolic Syndrome Clinical Trials Information presented on Clinical Trials Search is not intended to be a substitute for qualified health advice, trips or treatment by using a genuine doctor. We aren't doctors. Always consult your mD on Genomewide Search for Loci Underlying Metabolic Syndrome conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Genomewide Search for Loci Underlying Metabolic Syndrome Clinical research trials and Genomewide Search for Loci Underlying Metabolic Syndrome health trials take place in a lot of of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / projects is to answer specific human medical questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, like Genomewide Search for Loci Underlying Metabolic Syndrome. Genomewide Search for Loci Underlying Metabolic Syndrome Clinical Trials and other clinical trials allow for volunteers to have health treatment alternatives before they are available to the general public. Many times the test subjects obtain treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Genomewide Search for Loci Underlying Metabolic Syndrome clinical trial. Subjects oftentimes recieve the most effective healthcare possible for their Genomewide Search for Loci Underlying Metabolic Syndrome condition. Hazards are a reality, however, and could include additional or frequent doctor visits, healthcare dangers (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "G" Clinical Trials Conditions > Genomewide Search for Loci Underlying Metabolic Syndrome  Genomewide Search for Loci Underlying Metabolic Syndrome
Genomewide Search for Loci Underlying Metabolic Syndrome
For Condition: Hypertension,Heart Diseases,Metabolic Syndrome X,Obesity,Cardiovascular Diseases,Hyperinsulinism,Insulin Resistance
Status: No longer recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To identify the genes involved in the metabolic syndrome.
Details: BACKGROUND: Metabolic syndrome, characterized by clustering of multiple metabolic abnormalities including abdominal obesity, dyslipidemia, hyperinsulinemia, hyperglycemia, and hypertension, is one of the most important risk factors for cardiovascular disease and stroke. Genetics play a significant role in determining the individual susceptibility to metabolic syndrome and the inter-individual variation in its associated phenotypes, though these genetic factors remain largely unknown. The long-term goal is to identify the metabolic syndrome susceptibility genes and their functional variants. DESIGN NARRATIVE: The goal of the research is to study the underlying phenotypic structure of the metabolic syndrome and to systematically search for genetic loci predisposing to the metabolic syndrome using the genome scan approach. The specific aims are: (1) to screen about 10,000 sibling pairs aged 40 to 64 years in Anqing, Anhui China, on intermediate phenotypes of the metabolic syndrome including body mass index, waist and hip circumference, serum lipid profiles (triglyceride, HDL-, LDL-, and total cholesterol), fasting serum glucose and insulin level, and blood pressure; (2) to study the underlying phenotypic structure of the metabolic syndrome in the about 10,000 ascertained sibling pairs using factor analysis; (3) to select and genome scan 800 nuclear families from the pool of the ascertained sibling pairs using Weber screening set 10 markers. Each selected nuclear family contains a "proband" and >=3 other family members. The values of the three most significant factors for metabolic syndrome in the factor analysis (see specific aim 2) will be used to classify "proband" status for each subject. A "proband" is defined as having >=2 out of 3 factor values falling into the same side of the 10/90 percentile tails of the corresponding age- and sex-adjusted population distributions; (4) to test for linkage in the genome-scanned families on intermediate phenotypes and factors of metabolic syndrome using the Unified Haseman-Elston method. In addition to the univariate test, linkage analysis will be performed using a novel multivariate version of the Unified H-E method, which has recently been proposed and shown to be significantly more powerful than the univariate test for traits with common genetic determinants; (5) to perform expansion or replication linkage studies on loci identified in the genome scan in 300-400 additional families with >=1 proband with a denser set of markers.
Eligibility:
Study Type: Observational, Natural History, Defined Population
Minimum Age/Maximum Age: 40 Years/64 Years
Genders: Both
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Overall Study Official:
XuXin, , Harvard School of Public Health
Additional Information:
Study ID Numbers: 1241;
Study Start Date: September 2003
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00074451
Other Hyperinsulinism Studies:
1. Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)
2. Adolescent Blood Pressure Variation and Ventricular Mass
3. Minneapolis Children's Blood Pressure Study
4. Divergence of Blood Pressure By Race in Adolescent Girls
5. Family Blood Pressure Program - HyperGEN
Related Studies:
Other Hyperinsulinism Clinical Trials
Other Clinical Trials
Other Clinical Trials
Genomewide Search for Loci Underlying Metabolic Syndrome
|
|
|
|
|
|
|
|
